Skip to main content
Top
Published in: AIDS and Behavior 8/2011

01-11-2011 | Original Paper

HIV-1 Effects on Neuropsychological Performance in a Resource-Limited Country, Zambia

Authors: Adelina Holguin, Mwanza Banda, Elizabeth J. Willen, Costantine Malama, Kaseya O. Chiyenu, Victor C. Mudenda, Charles Wood

Published in: AIDS and Behavior | Issue 8/2011

Login to get access

Abstract

Zambia has substantially been affected by the HIV/AIDS epidemic with prevalence rates at 14% in a population estimated at 12 million. Yet, the extent of HIV-associated neurocognitive disorders (HAND) in this population remains to be clearly understood. A series of culturally appropriate neuropsychological (NP) assessments [International HIV Dementia Scale (IHDS), Color Trails Test 1 and 2, Grooved pegboard Test, and Time Gait Test] were used to test the effects of HIV on NP performance of HIV seropositive and seronegative individuals. Twenty-two percent HIV positive individuals ARV naïve met the criteria for IHDS-defined NP impairment. Gender significantly influenced the performance on NP tests with females performing more poorly compared to males. Larger studies that will accommodate gender differences and age are necessary to generate appropriate norms in Zambia in order to better assess the prevalence of HAND in the developing country setting.
Literature
2.
go back to reference Grewal HM, Gupta S, Singh S. Opportunistic pathogens in AIDS: trends, diagnosis and priorities. Expert Rev Anti Infect Ther. 2008;6(2):163–6.PubMedCrossRef Grewal HM, Gupta S, Singh S. Opportunistic pathogens in AIDS: trends, diagnosis and priorities. Expert Rev Anti Infect Ther. 2008;6(2):163–6.PubMedCrossRef
3.
go back to reference Antinori A, Arendt G, Becker JT, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 2007;69:1789–99.PubMedCrossRef Antinori A, Arendt G, Becker JT, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 2007;69:1789–99.PubMedCrossRef
4.
go back to reference Navia BA, Jordan BD, Price RW. The AIDS dementia complex: I. Clinical features. Ann Neurol. 1986;19:524–7. Navia BA, Jordan BD, Price RW. The AIDS dementia complex: I. Clinical features. Ann Neurol. 1986;19:524–7.
5.
go back to reference Janssen RS, Nwanyanwu OC, Selik RM, Sehr-Green JK. Epidemiology of human immunodefciency virus encephalopathy in the United States. Neurology. 1992;42:1473–6. Janssen RS, Nwanyanwu OC, Selik RM, Sehr-Green JK. Epidemiology of human immunodefciency virus encephalopathy in the United States. Neurology. 1992;42:1473–6.
6.
go back to reference Epstein LG, Sharer LR, Gajdusek DC. Hypothesis: AIDS encephalopathy is due to primary and persistent infection of the brain with a human retrovirus of the lentivirus subfamily. Med Hypotheses. 1986;21(1):87–96.PubMedCrossRef Epstein LG, Sharer LR, Gajdusek DC. Hypothesis: AIDS encephalopathy is due to primary and persistent infection of the brain with a human retrovirus of the lentivirus subfamily. Med Hypotheses. 1986;21(1):87–96.PubMedCrossRef
7.
go back to reference Heaton RK, Marcotte TD, Rivera Mindt M, et al. The impact of HIV-associated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc. 2004;10:317–31.PubMedCrossRef Heaton RK, Marcotte TD, Rivera Mindt M, et al. The impact of HIV-associated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc. 2004;10:317–31.PubMedCrossRef
8.
go back to reference Sacktor N, Skolasky RL, Ernst T, et al. A multicenter study of two magnetic resonance spectroscopy techniques in individuals with HIV dementia. J Magn Reson Imaging. 2005;21(4):325–33.PubMedCrossRef Sacktor N, Skolasky RL, Ernst T, et al. A multicenter study of two magnetic resonance spectroscopy techniques in individuals with HIV dementia. J Magn Reson Imaging. 2005;21(4):325–33.PubMedCrossRef
9.
go back to reference McArthur J, Hoover DR, Bacellar H, et al. Dementia in AIDS patients: incidence and risk factors. Neurology. 1993;43:2245–51.PubMed McArthur J, Hoover DR, Bacellar H, et al. Dementia in AIDS patients: incidence and risk factors. Neurology. 1993;43:2245–51.PubMed
10.
go back to reference Belec L, Martin PMV, Vohito MD, et al. Low prevalence of neuro-psychiatric clinical manifestations in central Africa patients with acquired immune deficiency syndrome. Trans Roy Soc Trop Med Hyg. 1989;83:844–6.PubMedCrossRef Belec L, Martin PMV, Vohito MD, et al. Low prevalence of neuro-psychiatric clinical manifestations in central Africa patients with acquired immune deficiency syndrome. Trans Roy Soc Trop Med Hyg. 1989;83:844–6.PubMedCrossRef
11.
go back to reference Howlett WP, Nkya WM, Mmuni KA, Missalek WR. Neurological disorders in AIDS and HIV disease in the northern zone of Tanzania. AIDS. 1989;3:289–96.PubMedCrossRef Howlett WP, Nkya WM, Mmuni KA, Missalek WR. Neurological disorders in AIDS and HIV disease in the northern zone of Tanzania. AIDS. 1989;3:289–96.PubMedCrossRef
12.
go back to reference Perriens JH, Mussa M, Laubeya MK, et al. Neurological complications of HIV-1 seropositive internal medicine inpatients in Kinshasa, Zaire. J Acquir Immune Defic Syndr. 1992;5:333–40.PubMed Perriens JH, Mussa M, Laubeya MK, et al. Neurological complications of HIV-1 seropositive internal medicine inpatients in Kinshasa, Zaire. J Acquir Immune Defic Syndr. 1992;5:333–40.PubMed
13.
go back to reference Sebit MB. Neuropsychiatric HIV-1 infection study: in Kenya and Zaire cross-sectional phase I and II. Central Afr J Med. 1995;41(10):315–22. Sebit MB. Neuropsychiatric HIV-1 infection study: in Kenya and Zaire cross-sectional phase I and II. Central Afr J Med. 1995;41(10):315–22.
14.
go back to reference Roberston KR, Nakasujja N, Wong M, et al. Pattern of neuropsychological performance among HIV positive patients in Uganda. BMC Neurol. 2007;7(8):1–7. Roberston KR, Nakasujja N, Wong M, et al. Pattern of neuropsychological performance among HIV positive patients in Uganda. BMC Neurol. 2007;7(8):1–7.
15.
go back to reference Salawu FK, Bwala SA, Wakil MA, et al. Cognitive function in HIV-seropositive Nigerians without AIDS. J Neurol Sci. 2008;267:142–6.PubMedCrossRef Salawu FK, Bwala SA, Wakil MA, et al. Cognitive function in HIV-seropositive Nigerians without AIDS. J Neurol Sci. 2008;267:142–6.PubMedCrossRef
16.
go back to reference Njamnshi AK, Bissek AC, Ongolo-Zogo P, et al. Risk factors for HIV-associated neurocognitive disorders (HAND) in sub-Saharan Africa: the case of Yaounde-Cameroon. J Neurol Sci. 2009;285(1–2):149–53.PubMedCrossRef Njamnshi AK, Bissek AC, Ongolo-Zogo P, et al. Risk factors for HIV-associated neurocognitive disorders (HAND) in sub-Saharan Africa: the case of Yaounde-Cameroon. J Neurol Sci. 2009;285(1–2):149–53.PubMedCrossRef
17.
go back to reference Wong MH, Roberston KR, Nakasujja N, et al. Frequency of and risk factors for HIV dementia in an HIV clinic in sub-Sahara Africa. Neurology. 2007;68:350–5.PubMedCrossRef Wong MH, Roberston KR, Nakasujja N, et al. Frequency of and risk factors for HIV dementia in an HIV clinic in sub-Sahara Africa. Neurology. 2007;68:350–5.PubMedCrossRef
18.
go back to reference Sacktor NC, Wong M, Nakasujja N, et al. The international HIV dementia scale: a new rapid screening test for HIV dementia. AIDS. 2005;19(13):1367–74.PubMed Sacktor NC, Wong M, Nakasujja N, et al. The international HIV dementia scale: a new rapid screening test for HIV dementia. AIDS. 2005;19(13):1367–74.PubMed
19.
go back to reference Kanmogne GD, Kuate CT, Cysique LA, et al. HIV-associated neurocognitive disorders in sub-Saharan Africa: a pilot study in Cameroon. BMC Neurol. 2010;10:60.PubMedCrossRef Kanmogne GD, Kuate CT, Cysique LA, et al. HIV-associated neurocognitive disorders in sub-Saharan Africa: a pilot study in Cameroon. BMC Neurol. 2010;10:60.PubMedCrossRef
20.
go back to reference Clifford DB, Mitike MT, Mekonnen Y, et al. Neurological evaluation of untreated human immunodeficiency virus infected adults in Ethiopia. J Neurovirol. 2007;13(1):67–72.PubMedCrossRef Clifford DB, Mitike MT, Mekonnen Y, et al. Neurological evaluation of untreated human immunodeficiency virus infected adults in Ethiopia. J Neurovirol. 2007;13(1):67–72.PubMedCrossRef
21.
go back to reference Lawler K, Mosepele M, Ratcliffe S, et al. Neurocognitive impairment among HIV-positive individuals in Botswana: a pilot study. J Int AIDS Soc. 2010;13:15.PubMedCrossRef Lawler K, Mosepele M, Ratcliffe S, et al. Neurocognitive impairment among HIV-positive individuals in Botswana: a pilot study. J Int AIDS Soc. 2010;13:15.PubMedCrossRef
22.
go back to reference Joska JA, Fincham DS, Stein DJ, Paul RH, Seedat S. Clinical correlates of HIV-associated neurocognitive disorders in South Africa. AIDS Behav. 2010;14(2):371–8.PubMedCrossRef Joska JA, Fincham DS, Stein DJ, Paul RH, Seedat S. Clinical correlates of HIV-associated neurocognitive disorders in South Africa. AIDS Behav. 2010;14(2):371–8.PubMedCrossRef
23.
go back to reference Joska JA, Westgarth-Taylor J, Myer L, et al. Characterization of HIV-associated neurocognitive disorders among individuals starting antiretroviral therapy in South Africa. AIDS Behav. 2010. doi:10.1007/s10461-010-9744-6. Joska JA, Westgarth-Taylor J, Myer L, et al. Characterization of HIV-associated neurocognitive disorders among individuals starting antiretroviral therapy in South Africa. AIDS Behav. 2010. doi:10.​1007/​s10461-010-9744-6.
24.
go back to reference Ganasen KA, Fineham D, Smit TK, Seedat S, Stein D. Utility of the HIV Dementia Scale (HDS) in identifying HIV dementia in a South African sample. J Neurol Sci. 2008;269:62–4.PubMedCrossRef Ganasen KA, Fineham D, Smit TK, Seedat S, Stein D. Utility of the HIV Dementia Scale (HDS) in identifying HIV dementia in a South African sample. J Neurol Sci. 2008;269:62–4.PubMedCrossRef
25.
go back to reference Power C, Selnes OA, Grim JA, McArthur JC. HIV dementia scale: a rapid screening test. J Acquir Immune Defic Syndr Human Retrovirol. 1995;8(3):273–8.CrossRef Power C, Selnes OA, Grim JA, McArthur JC. HIV dementia scale: a rapid screening test. J Acquir Immune Defic Syndr Human Retrovirol. 1995;8(3):273–8.CrossRef
26.
go back to reference Central Statistical Office, Zambia Demographic and Health Survey 2007, Ministry of Health (MOH) TDRCT, University of Zambia, and Macro International Inc. Calverton, Maryland, USA: CSO and Macro International Inc; 2009. Central Statistical Office, Zambia Demographic and Health Survey 2007, Ministry of Health (MOH) TDRCT, University of Zambia, and Macro International Inc. Calverton, Maryland, USA: CSO and Macro International Inc; 2009.
27.
go back to reference Stringer JS, Zulu I, Levy J, et al. Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. JAMA. 2006;296(7):782–93.PubMedCrossRef Stringer JS, Zulu I, Levy J, et al. Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. JAMA. 2006;296(7):782–93.PubMedCrossRef
28.
go back to reference Heaton RK, Clifford DB, Franklin DR Jr, et al. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER study. Neurology. 2010;75(23):2087–96.PubMedCrossRef Heaton RK, Clifford DB, Franklin DR Jr, et al. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER study. Neurology. 2010;75(23):2087–96.PubMedCrossRef
29.
go back to reference Sattler J. Assessment for children. 3rd ed. In: Sattler J, editor. San Diego, CA: Publisher Inc.; 1982. Sattler J. Assessment for children. 3rd ed. In: Sattler J, editor. San Diego, CA: Publisher Inc.; 1982.
30.
go back to reference Crum RM, Anthony JC, Bassett SS, Folstein MF. Population-based norms for the mini-mental state examination by age and educational level. JAMA. 1993;269(18):2386–91.PubMedCrossRef Crum RM, Anthony JC, Bassett SS, Folstein MF. Population-based norms for the mini-mental state examination by age and educational level. JAMA. 1993;269(18):2386–91.PubMedCrossRef
31.
go back to reference Mungas D. In-office mental status testing: a practical guide. Geriatrics. 1991; 46(7):54–8, 63, 66. Mungas D. In-office mental status testing: a practical guide. Geriatrics. 1991; 46(7):54–8, 63, 66.
32.
go back to reference Maj M, Elia’D L, Satz P, et al. Evaluation of two new neuropsychological tests designed to minimize cultural bias in the assessment of HIV-1 seropositive persons: a WHO study. Arch Clin Neuropsychol. 1993;8:123–35.PubMed Maj M, Elia’D L, Satz P, et al. Evaluation of two new neuropsychological tests designed to minimize cultural bias in the assessment of HIV-1 seropositive persons: a WHO study. Arch Clin Neuropsychol. 1993;8:123–35.PubMed
33.
go back to reference Maj M, Satz P, Janssen R, et al. WHO neuropsychiatric AIDS study, cross-sectional phase II. Arch Gen Psychiatry. 1994;51:51–61.PubMed Maj M, Satz P, Janssen R, et al. WHO neuropsychiatric AIDS study, cross-sectional phase II. Arch Gen Psychiatry. 1994;51:51–61.PubMed
34.
go back to reference Roberston KR, Parsons TD, Sidtis J, et al. Time gait test: normative data for the assessment of the AIDS dementia complex. J Clin Exp Neuropsychol. 2006;28:1053–64.CrossRef Roberston KR, Parsons TD, Sidtis J, et al. Time gait test: normative data for the assessment of the AIDS dementia complex. J Clin Exp Neuropsychol. 2006;28:1053–64.CrossRef
36.
go back to reference Selnes OA, Galai N, Bacellar H, et al. Cognitive performance after progression to AIDS: a longitudinal study from the Multicenter AIDS Cohort Study. Neurology. 1995;45(2):267–75.PubMed Selnes OA, Galai N, Bacellar H, et al. Cognitive performance after progression to AIDS: a longitudinal study from the Multicenter AIDS Cohort Study. Neurology. 1995;45(2):267–75.PubMed
37.
go back to reference Bouwman FH, Skolasky RL, Hes D, et al. Variable progression of HIV-associated dementia. Neurology. 1998;50(6):1814–20.PubMed Bouwman FH, Skolasky RL, Hes D, et al. Variable progression of HIV-associated dementia. Neurology. 1998;50(6):1814–20.PubMed
38.
go back to reference Chiesi A, Seeber AC, Dally LG, et al. AIDS dementia complex in the Italian National AIDS Registry: temporal trends (1987–93) and differential incidence according to mode of transmission of HIV-1 infection. J Neurol Sci. 1996;144(1–2):107–13.PubMedCrossRef Chiesi A, Seeber AC, Dally LG, et al. AIDS dementia complex in the Italian National AIDS Registry: temporal trends (1987–93) and differential incidence according to mode of transmission of HIV-1 infection. J Neurol Sci. 1996;144(1–2):107–13.PubMedCrossRef
39.
go back to reference Everall I, Vaida F, Khanlou N, et al. Cliniconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy. J Neurovirol. 2009;15(5–6):360–70.PubMedCrossRef Everall I, Vaida F, Khanlou N, et al. Cliniconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy. J Neurovirol. 2009;15(5–6):360–70.PubMedCrossRef
40.
go back to reference Roberston KR, Kapoor C, Robertson WT, et al. No gender differences in the progression of nervous system disease in HIV infection. J Acquir Immune Defic Syndr. 2004;36(3):817–22.CrossRef Roberston KR, Kapoor C, Robertson WT, et al. No gender differences in the progression of nervous system disease in HIV infection. J Acquir Immune Defic Syndr. 2004;36(3):817–22.CrossRef
41.
go back to reference Sacktor N, McDermott MP, Marder K, et al. HIV-associated cognitive impairment before and after the advent of combination therapy. J Neurovirol. 2002;8(2):136–42.PubMedCrossRef Sacktor N, McDermott MP, Marder K, et al. HIV-associated cognitive impairment before and after the advent of combination therapy. J Neurovirol. 2002;8(2):136–42.PubMedCrossRef
42.
go back to reference Cole MA, Margolick JB, Cox C, et al. Longitudinally preserved psychomotor performance in long-term asymptomatic HIV-infected individuals. Neurology. 2007;69(24):2213–20.PubMedCrossRef Cole MA, Margolick JB, Cox C, et al. Longitudinally preserved psychomotor performance in long-term asymptomatic HIV-infected individuals. Neurology. 2007;69(24):2213–20.PubMedCrossRef
43.
go back to reference Central Statistical Office. Zambia Demographic and Health Survey 2001–2002. In: Central Board of Health (CBOH), ORC Macro. Calverton, Maryland: Central Statistical Office, Central Board of Health, and ORC Macro; 2003. Central Statistical Office. Zambia Demographic and Health Survey 2001–2002. In: Central Board of Health (CBOH), ORC Macro. Calverton, Maryland: Central Statistical Office, Central Board of Health, and ORC Macro; 2003.
Metadata
Title
HIV-1 Effects on Neuropsychological Performance in a Resource-Limited Country, Zambia
Authors
Adelina Holguin
Mwanza Banda
Elizabeth J. Willen
Costantine Malama
Kaseya O. Chiyenu
Victor C. Mudenda
Charles Wood
Publication date
01-11-2011
Publisher
Springer US
Published in
AIDS and Behavior / Issue 8/2011
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-011-9988-9

Other articles of this Issue 8/2011

AIDS and Behavior 8/2011 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.